Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life.
Although this Mylan site remains active for now, we encourage you to visit the Viatris site to learn more about our commitment to increasing access to quality medicines for patients when and where they need them.
Mylan also is proud to do business in these locations.
Mylan is committed to supporting Canadian physicians through education, patient materials, and risk management programs.
Clarus® CLEAR™ Program
Clarus® (isotretinoin capsules) is used to treat the most severe form of acne (nodular acne) that cannot be cleared up by any other acne treatments, including antibiotics. Providing information and support materials for Clarus® patients and healthcare professionals.
Mylan-Buprenorphine/Naloxone (M-BN) is part of a medical, social and psychological treatment program for adults undergoing substitution treatment for problematic opioid drug dependence.
The Buprenorphine and Naloxone Education Program (BNEP) is a risk management program that helps to ensure the safe and effective use of the drug. This program provides training for physicians, nurses, pharmacists and other healthcare professionals in the use of M-BN sublingual tablets.
Mylan-Bosentan is prescribed for the treatment of pulmonary arterial hypertension. Health Canada has deemed Mylan-Bosentan as bioequivalent to Tracleer®.
Campral® (acamprosate calcium delayed release tablets) is used to help alcohol dependent people abstain from drinking alcohol. Acamprosate acts centrally and appears to restore the normal balance between neuronal excitation and inhibition that becomes altered as a result of chronic alcohol exposure. Campral® should be used as part of a complete treatment program that includes counselling.
Clozaril® is a product of HLS Therapeutics Inc.
Tracleer® is a product of Actelion Pharmaceuticals Ltd.
You are now leaving the Mylan Canada site for another Mylan affiliate site or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies. Links to Mylan affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site. Regulatory requirements, data requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country. Mylan Canada accepts no responsibility for the content of other sites.